3rd ESTRO Forum 2015 The aim was to review existing bladder-filling protocols to establish if they provide effective consistent filling throughout treatment and to see if this impacts toxicity. Materials and Methods: All patients receiving radical radiotherapy for prostate, rectal and gynaecological cancers over a 6 month period were included. Bladder scan measurements were conducted at radiotherapy planning and US was performed 3 times weekly throughout treatment. The RTOG toxicity score was reviewed retrospectively. Results: 12 patients with prostate cancer, 3 with rectal cancer and 2 with cervical cancer were identified. Bladder filling protocols were adhered to in that the number of preparatory cups of water drunk was consistent. US assessment showed significant variation in bladder volumes from the original volume at planning. For prostate patients this ranged from +462mls to -333mls, for rectal patients +320mls to -380mls, and for cervical patients +185mls to -350mls. The mean variation of median values for each group was 76.25mls, 166.7mls and 160mls respectively, giving a collective mean across all patients of 102mls. The variation in bladder filling did not affect patients' toxicity.
The aim was to review existing bladder-filling protocols to establish if they provide effective consistent filling throughout treatment and to see if this impacts toxicity. Materials and Methods: All patients receiving radical radiotherapy for prostate, rectal and gynaecological cancers over a 6 month period were included. Bladder scan measurements were conducted at radiotherapy planning and US was performed 3 times weekly throughout treatment. The RTOG toxicity score was reviewed retrospectively. Results: 12 patients with prostate cancer, 3 with rectal cancer and 2 with cervical cancer were identified. Bladder filling protocols were adhered to in that the number of preparatory cups of water drunk was consistent. US assessment showed significant variation in bladder volumes from the original volume at planning. For prostate patients this ranged from +462mls to -333mls, for rectal patients +320mls to -380mls, and for cervical patients +185mls to -350mls. The mean variation of median values for each group was 76.25mls, 166.7mls and 160mls respectively, giving a collective mean across all patients of 102mls. The variation in bladder filling did not affect patients' toxicity.
Conclusions:
It is important to reliably achieve bladder filling throughout treatment that is consistent with the bladder volume on which the radiotherapy plan is based otherwise it may impact both treatment outcomes and toxicity. Despite having standardised preparation protocols, consistent filling is challenging. Variation may be due to patient compliance, time lag between US to planning CT, or time on treatment couch, during which there is continued bladder filling, introducing significant changes in bladder volume. Standardising bladder-filling protocols, patient education, and minimizing time between bladder US and treatment time all play important roles in improving consistent bladder filling. Purpose/Objective: Setup errors are inherent part of any radiation treatment. It is introduced by virtue of manual as well as machine related attribute which to a certain extent can be controlled by daily meticulous procedural checks. They are defined as the difference between the actual and intended position with respect to radiation delivery. The Aim of our study is to assess setup error and its frequency in cases of frameless stereotactic radiotherapy given in case of brain tumors without frame with the help of orfit ray cast with open mouth and All in One base plate. Materials and Methods: A total of 11 patients undergoing treatments in between 3 to 6 fraction on linear accelerator with HD MLC at our hospital by frameless stereotactic radiotherapy for lesions metastatic to brain. Each patient was planned without rigid frame, though immobilization was achieved by orfit cast. Daily verification of setup was done with the help of CBCT. Analysis of daily setup error and shift thus applied was calculated for each patient at the end of his/her treatment. Results: In our present study, it was found that the displacement in antero-posterior, supero-inferior and mediolateral direction was 0.137+0.089cm, 0.154+ 0.056 cm and 0.199 + 0.153 cm respectively. It was seen that the set up errors ranged between 0.04 -0.26cm for antero-posterior, 0.1 -0.3cm for supero-inferior and 0.04 -0.58 cm for mediolateral direction. Conclusions: Our present study has come to the conclusion that frameless stereotactic radiotherapy cranial field mean set-up error was <0.2 cm in all X Y Z coordinates. Caution is warranted against adopting generic margin as different margin generating recipes lead to a different probability of target volume coverage. The method used in this study was: 1. To perform a set of two setup images (MV/MV or KV/MV) at the beginning of the session and to repeat them at the end of the session for 5 treatment sessions. 2. To compare the setup images taken at the beginning and at the end of each session, with the reference images (DRRs) obtained from the Eclipse Planning System, by means of the 'Off-line review' software (both softwares from Varian Medical Systems). The differences obtained in the aforementioned comparison, were introduced in a spreadsheet and they were carefully analyzed in order to determine if the patient position was kept within tolerances during each of the analyzed sessions. The tolerance for palliative treatments in the image protocol implemented in our hospital is ± 0.7cm in each of the three axes.
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Results: 81% of the patients were within tolerance in each fraction of the radiotherapy treatment, and only 19% exceeded the tolerance level for some of the treatment fractions ( figure 1) . Quantifying the differences found in any axis and for any fraction, it can be seen that 90% are within the tolerance level, and 8% are between 0.5cm and 0.6cm. Only 2% exceeds the limit of 0,7cm (figure 2).
Conclusions:
We found a good reproducibility in the daily position for patients with well controlled pain. We can conclude that the positioning method and other techniquerelated parameters that we use for palliative treatments are adequate to guarantee a good reproducibility of patient position during the radiotherapy treatment. These results show the importance of keeping a well controlled pain to ensure a good treatment. Purpose/Objective: Aim of this work was to evaluate the accuracy in the positioning of two different set of commercial thermoplastic mask systems: Easy Frame (Candor TM ) (group A) and Double Shell Positioning System (MacroMedics ® DSPS ® ) (group B). A group of patients undergoing SNC and H&N treatments, both stereotactic or with conventional fractionation was chosen. The translational shifts applied after each CBCT and prior to irradiation with Varian TM TrueBeamSTx were registered. Rotations around the three axes were calculated using the MIM software TM . A comparison in terms of absolute displacement and rotations was performed in order to evaluate if a significant difference could exist between the two systems. Materials and Methods: 10 patients were chosen for a total of 26 CBCT analyzed in each arm of the study. For every patient, the change in the position applied by the physician after the CBCT was registered and a mean shift was calculated. Since our set-up does not allow to apply rotations to the couch, the MIM software was used to evaluate rotations: the CBCTs and the plan CT were imported and a box based rigid fusion was performed and checked by a trained physician. Shifts in the three directions and rotations were acquired. The mean value of the displacement (along x, y and z) and of the rotations was calculated and a 3D displacement (3Dd) value was obtained, together with the S and s values of the distributions respectively representing the distribution of systematic errors and of population random errors 1,2 . 1 Van Herk M. Sem. Rad. Onc. 2004; 14 2 Amelio D. et al. J Radiat Res. 2013, 54 Results: In table 1 the group mean 3Dd of the clinical applied translations (APP) for the two groups of patient is reported, together with the 3D displacement and rotations obtained with the MIM fusions, with SDs. The applied 3Dd varied between 0.4 and 6.2 mm (group A) and 0.6 and 8.1 mm (group B). Maximum Σ and σ were 2.3 (scored along the vertical direction, y) and 1.0 mm (registered along the cranial-caudal direction, z), respectively for group A and 2.7 and 1.8 mm (both registered along z) for group B. Mean differences in translational shifts between MIM and applied shifts were of 0.19 mm (A) 0.20 mm (B) along x, of -0.14 (A) and -0.10 mm (B) along y and of -0.23 (A) and 0.19 mm (B) along z, with a maximum deviation of 3.9 mm (a) and 3.5 mm (B) respectively along y and z.
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Conclusions:
Our analysis showed that no significant difference between the two positioning systems exist. The results obtained with MIM demonstrate that both systems are able to keep patient head rotations minimal and that the possibility of applying roto traslations instead of simple translations do not give a substantial reduction of shifts. A widest set of patient is needed in order to improve the statistic and to make the evaluation more robust. It has also to be noticed that the set B was adopted recently in our
